KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBT Margin (2016 - 2025)

Chemed (CHE) has 17 years of EBT Margin data on record, last reported at 16.49% in Q4 2025.

  • For Q4 2025, EBT Margin fell 228.0% year-over-year to 16.49%; the TTM value through Dec 2025 reached 14.06%, down 237.0%, while the annual FY2025 figure was 14.06%, 237.0% down from the prior year.
  • EBT Margin reached 16.49% in Q4 2025 per CHE's latest filing, up from 13.37% in the prior quarter.
  • Across five years, EBT Margin topped out at 19.73% in Q4 2023 and bottomed at 11.49% in Q2 2025.
  • Average EBT Margin over 5 years is 15.53%, with a median of 15.81% recorded in 2024.
  • Peak YoY movement for EBT Margin: plummeted -95450bps in 2021, then skyrocketed 466bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 17.77% in 2021, then decreased by -15bps to 15.07% in 2022, then soared by 31bps to 19.73% in 2023, then decreased by -5bps to 18.77% in 2024, then dropped by -12bps to 16.49% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 16.49% in Q4 2025, 13.37% in Q3 2025, and 11.49% in Q2 2025.